Patent: 8,029,992
Summary for Patent: 8,029,992
| Title: | Methods of evaluating cells and cell cultures |
| Abstract: | Methods of evaluating the composition of a cell culture (e.g., to distinguish chondrocytes from fibroblasts) and methods for evaluating the phenotype of an individual cell (e.g., as a chondrocyte) are disclosed. The methods may be used, for example, for assessing chondrocyte cultures used for treatment of cartilage defects. In some embodiments, the invention involves identifying cell culture composition or the identity of a cell based on expression level of a fibroblast marker. In other embodiments, the invention involves comparing expression levels of at least one chondrocyte marker and at least one fibroblast marker in a cell culture sample or in an individual cell. In illustrative embodiments, the chondrocyte marker is hyaluronan and proteoglycan link protein 1 (HAPLN1), and the fibroblast marker is microfibrillar associated protein 5 (MFAP5). |
| Inventor(s): | Stephen M. Rapko, Stephen J. Duguay |
| Assignee: | Vericel Corp |
| Application Number: | US12/098,033 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,029,992
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Vericel Corporation | MACI | autologous cultured chondrocytes on porcine collagen membrane | Cell Sheets | 125603 | December 13, 2016 | 8,029,992 | 2028-04-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,029,992
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 066403 | ⤷ Start Trial |
| Austria | E541211 | ⤷ Start Trial |
| Australia | 2008237332 | ⤷ Start Trial |
| Brazil | PI0809902 | ⤷ Start Trial |
| Canada | 2682948 | ⤷ Start Trial |
| China | 101680881 | ⤷ Start Trial |
| Denmark | 2132562 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
